Frontlight ResearchEarly access
Trial site
Netaji Subhas chandra Bose Cancer Research Institute
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC1 trial
- Karyopharm Therapeutics Inc1 trial
Running trials
Active, not recruiting
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Site data: ClinicalTrials.govUpdated 12 Nov 2026